4//SEC Filing
White Barbara 4
Accession 0001209191-21-007727
CIK 0001595097other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:26 PM ET
Size
8.1 KB
Accession
0001209191-21-007727
Insider Transaction Report
Form 4
White Barbara
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-02+307,300→ 307,300 totalExercise: $2.58Exp: 2031-02-02→ Common Stock (307,300 underlying) - Award
Stock Option (right to buy)
2021-02-02+307,300→ 307,300 totalExercise: $2.58Exp: 2031-02-02→ Common Stock (307,300 underlying)
Footnotes (2)
- [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022.
- [F2]Represents a special retention award comprised of options to purchase common stock. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeother
Related Parties
1- filerCIK 0001625844
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:26 PM ET
- Size
- 8.1 KB